TRAIL trimers, methods and uses therefor
AssigneeWashington University
InventorsWilliam G. Hawkins, Dirk Spitzer, Richard S. Hotchkiss
Life of this patent
Estimating the term…
Loading patent…
AssigneeWashington University
InventorsWilliam G. Hawkins, Dirk Spitzer, Richard S. Hotchkiss
Estimating the term…
Disclosed are TNF-related apoptosis-inducing ligand (TRAIL) trimers (TR3) and nucleic acids encoding covalently linked TRAIL trimers. A TRAIL trimer can have greater stability compared to native TRAIL, and can retain the native killing ability of TRAIL. Target specificity of a TR3 can be shown by blocking its activity with soluble death receptor 5 (DR5-Fc). Also disclosed are modified TRAIL trimers and nucleic acids encoding them. These modifications include additional functional domains, such as antibody fragments (scFvs). A TR3 comprising an additional functional domain can allow for cell-specific delivery of the TR3. In some configurations, a modification such as the addition of a functional domain can be stoichiometrically controlled. In some configurations, a modification can be inconsequential with regard to the bioactivity of TRAIL. In various embodiments, a TR3, including a modified TR3, can be a cancer-selective drug. In some configurations, a TR3 that comprises an additional biologically active moiety such as a functional domain of a protein can have fewer off-target toxicities compared to TRAIL alone. In some configurations, a TR3 that comprises an additional biologically active moiety such as a functional domain of a protein can have enhanced killing capacities compared to the moiety alone. In some aspects, TR3 activity can be targeted to an RBC membrane. The inventors disclose TR3-decorated RBCs that target cell killing in a model of pancreatic cancer.
A trimer of a TNF-related apoptosis-inducing ligand (TRAIL), comprising three consecutive extracellular TRAIL domains fused together in a head-to-tail configuration.
A method of inducing apoptosis in a tumor cell, comprising contacting the cell with a trimer of a TNF-related apoptosis-inducing ligand (TRAIL), comprising three consecutive extracellular TRAIL domains fused together in a head-to-tail configuration.
Dependencies are inferred from the claim text.